# Trade Mark Journal No.2025/046 14 November 2025

## WO0000001884614 (35,38,42,44)

Office of origin: United States of America

Date of International Registration:11 July 2025
Date of designation in the UK: 11 July 2025

International priority date claimed: 9 April 2025 (United States of America) (99128687)

Class 35
  Collecting and analyzing claims data from healthcare organizations for business purposes; collection and analysis of quality metric data for a network of health care providers for business purposes; analyzing and compiling business data in the fields of nucleic acid sequencing, genotyping, medical research, medical diagnostics, clinical research, clinical diagnostics, drug development research, and genetic testing.
Class 38
  Providing access to an electronic exchange of medical records across a nationwide health information network; electronic exchange of medical records across a nationwide health information network.
Class 42
  Providing online non-downloadable computer software for the custom design and ordering of assays, agents, enzymes, nucleotides, nucleic acids, buffers, chemical preparations, biological preparations, and reagents in the fields of medical research, medical diagnostics, clinical research, clinical diagnostics, drug development research, and genetic testing; providing online non-downloadable computer software that enables users to store, analyze, integrate, exchange, and share data in the fields of nucleic acid sequencing, medical research, clinical research, drug development research, and genetic testing; providing scientific research information in the fields of nucleic acid sequencing, medicine, medical diagnostics, clinical diagnostics, medical research, clinical research, drug development, life sciences, biology, microbiology, biotechnology, genetics, oncology, and healthcare to others via an online searchable database; providing online non-downloadable computer software featuring de-identified electronic health records and de-identified patient genetic information for medical diagnostic and treatment purposes; providing medical and scientific research information via a website on advances in the fields of human health and diagnostic treatment strategies of human diseases, human genetic research and development, and pharmaceutical research and development; genome sequencing and analysis services for scientific and research purposes; providing computer programming services that enable queries of a healthcare database for the purpose of retrieving health information; providing online non-downloadable computer software for collecting, storing, and analyzing de-identified electronic health records and de-identified patient genetic information.
Class 44
  Nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; providing healthcare information from multiple entities via an online searchable database relating to healthcare issues; medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses.

Truveta Inc.

Representative: Elizabeth Breakstone Hillis Clark Martin & Peterson P.S., 999 Third Avenue, Suite 4600, Seattle WA 98104, UNITED STATES OF AMERICA